The DNA and Gene Cloning Services Market Size is valued at 3.18 Billion in 2022 and is predicted to reach 14.88 Billion by the year 2031 at a 19.2 % CAGR during the forecast period for 2023-2031.
The progress of genetic engineering and cloning techniques has made it possible to alter the genomes of microorganisms, allowing for synthesizing compounds with diverse research and medicinal applications. A method that assembles DNA sequences of interest by cutting and pasting them together using enzymes. The recombined DNA sequences can be inserted into vectors, molecules that transport DNA into a host cell. The specific recombined DNA sequence can be replicated or translated within this host cell. Gene probes produced using gene cloning offer a range of applications, including early detection of genetic disorders, forensic investigations, and routine diagnosis. This technology's industrial application gives novel antibiotics in the form of antimicrobial peptides and recombinant cytokines that can be employed as therapeutic agents.
Also, with the help of the cloning technique, It is possible to isolate a specific gene and identify its nucleotide sequence, and DNA control sequences can be found and examined. The function of proteins, enzymes, and RNA can be studied, and Mutations are detectable. Cloning techniques at the molecular level are fundamental to a wide variety of scientific fields in modern biology and medicine.
The market for DNA cloning and gene cloning services is expected to experience consistent growth in the years to come as a result of the rising demand for gene therapies and the introduction and adoption of novel and advanced DNA cloning technologies. These two factors are expected to drive the market for DNA cloning and gene cloning services. A favourable funding landscape for gene synthesis and cloning services, technological improvement in cloning and subcloning services, and an increase in synergistic activities in the market are some of the factors supporting the market's growth. In Aug 2020, Thermo Fisher revealed a $76 million expansion at its US location as part of its ongoing $650 million bioprocessing revamp.
While the worldwide gene synthesis market is expected to proliferate over the next few years, its development may be limited by a lack of qualified professionals and lengthy approval processes. Growth prospects may arise as a result of technological developments, strategic partnerships, and mergers and acquisitions in the biomedical and healthcare industries.
Market Segmentation:
The DNA and Gene Cloning Services market is segmented into three main aspects, the type of services offered, which comprises Custom cloning, gene synthesis, sub-cloning and others. The second segment is the type of gene that includes complex gene and standard gene as sub-segments. The third significant segment is the end-user industry, and this comprises Academic and R&D, Pharmaceutical and Biotechnology Companies and other industries.
DNA and gene cloning are currently receiving a lot of attention in the life science research market in North America, which has led to increased investments, funding, and collaborations for industrial expansion in the foreseeable future.
Competitive Landscape:
Some Major Key Players In The DNA And Gene Cloning Services Market:
- Bio-Techne,
- Charles River Laboratories,
- Curia,
- Eurofins,
- GenScript,
- Integrated DNA Technologies,
- MedGenome,
- Sino Biological,
- Syngene,
- Twist Bioscience,
- Thermo Fisher Scientific Inc.,
- Eurofins Scientific,
- Merck KGaA,
- Takara Bio Inc.,
- Lonza,
- Sartorius AG,
- Creative Biogene,
- Cellecta, Inc.,
- Synbio Technologies,
- TransGen Biotech Co., Ltd.,
- Dobuss (Canvax),
- Azenta US, Inc.,
- Macrogen, Inc.,
- Codex DNA, Inc.,
- Bio-Rad
DNA and Gene Cloning Services Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 3.18 Billion |
|
Revenue Forecast In 2031 |
USD 14.88 Billion |
|
Growth Rate CAGR |
CAGR of 19.2 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Type of Service Offered, Type of Gene, End-User Industry |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, Twist Bioscience, Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Lonza, Sartorius AG, Creative Biogene, Cellecta, Inc., Synbio Technologies, TransGen Biotech Co., Ltd., Dobuss (Canvax), Azenta US, Inc., Macrogen, Inc., Codex DNA, Inc., Bio-Rad, and other key players. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
